Saturday 17 October 2026
Export ORMP’s income statement to Excel — free account
Oramed Pharmaceuticals Inc.
ORMP Healthcare Biotechnology
In the quarter to June 2026, revenue grew 193.3%, EPS grew 493.8% and free cash flow grew 94.3%, each against the same quarter a year earlier.
4.07
0.11
−2.63%
Follow ORMP
Oramed Pharmaceuticals Inc. (ORMP) P/E ratio
As of 16 October 2026, Oramed Pharmaceuticals Inc. (ORMP) trades at a P/E ratio of 1.0×. Over the past ten years it has ranged from 0.0× (September 2025) to 25.6× (February 2024); the current reading is higher than 83% of that period. That is below the Biotechnology industry median of 8.5× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 1.9× | (89.29%) |
| FY2023 | 17.5× | — |
| FY2022 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2025 | 0.0× | — |
| Jun 2023 | 0.0× | — |
| Mar 2023 | 0.0× | — |
| Dec 2022 | 0.0× | — |
| 31 more quarters | Free account |
Against its own ten years
Low 0.0×
High 25.6×
Ten-year median
0.0×
Current reading's percentile
83
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ELDN Eledon Pharmaceuticals, Inc. compare | n/m |
| BCYC Bicycle Therapeutics PLC Sponsored ADR compare | n/m |
| WHWK Whitehawk Therapeutics, Inc. compare | n/m |
| CHRS Coherus Oncology, Inc. compare | n/m |
| IPHA Innate Pharma S.A. Sponsored ADR compare | n/m |
| DTIL Precision BioSciences, Inc. compare | n/m |
| ACOG Alpha Cognition Inc. compare | n/m |
| PEPG PepGen, Inc. compare | n/m |
| ORMP Oramed Pharmaceuticals Inc. | 1.0× |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)